Surgical venous thromboprophylaxis: a cross-sectional survey of canadian gynaecologic oncologists.
Venous thromboembolism (VTE) is a significant cause of morbidity and mortality following gynaecologic cancer surgery. The objective of this study was to assess the current practice for VTE prophylaxis among Canadian gynaecologic oncologists for both open and minimally invasive surgical techniques and to assess interest in participation in a clinical trial to examine this issue. Assessment of national thromboprophylaxis practices was achieved through an online survey technique, "Zoomerang." An invitation to complete the survey was sent out via email to members of the Society of Gynecologic Oncology of Canada. The majority of respondents (78%) believed surgical thromboprophylaxis to be indicated for all gynaecologic oncology patients, irrespective of an open versus minimally invasive approach. Current thromboprophylaxis practice patterns are variable, reflecting centre-specific challenges. Venous thromboembolism is an important and preventable complication of major gynaecologic surgery. A demonstrated lack of evidence and consensus regarding VTE prophylaxis following minimally invasive procedures for gynaecologic oncology patients necessitates further prospective study to evaluate the incidence, risk, treatment, and cost-effectiveness of prophylaxis.